BYAH // Park Ha Biological Technology Co. Ltd. (Class A)
FA <GO> NASDAQ RQD COCKPIT → CIK 0001986247 ↗ Consumer Discretionary • Package Goods/Cosmetics
$2.30 ▲ +0.04
(+1.71%)
MKT CAP: $7.9M • VOL: 2.2K
52W L $2 52W H $158
ROARABLE / RQD
D+ • 57/100
PIOTROSKI
5 / 9
BYAH // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-10-31 | FY 2024
FILED 2024-10-31 | FY 2023
FILED 2023-10-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.5M | $2.4M | $2.5M |
| YoY Revenue Growth % | +6.0% | -3.1% | — |
| Gross Profit | $2.4M | $2.2M | — |
| Gross Margin % | 94.4% | 91.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$24.1M | $793.7K | $1.2M |
| Operating Margin % | -80.0% | 33.3% | 48.0% |
| Net Income (GAAP) | -$24.4M | $478.6K | $852.0K |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $85.9K | $960.5K | $126.5K |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | $85.9K | $960.5K | $126.5K |
| FCF Margin % | 3.4% | 40.3% | 5.1% |
| Return on Invested Capital (ROIC %) | — | — | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | — | — | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR BYAH.